Danske Bank A S Takes Position in Danaher Corporation $DHR

Danske Bank A S purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 151,052 shares of the conglomerate’s stock, valued at approximately $108,763,000.

Other large investors have also recently bought and sold shares of the company. Main Street Group LTD bought a new position in Danaher in the 1st quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher during the second quarter worth $25,000. JPL Wealth Management LLC acquired a new position in shares of Danaher during the third quarter valued at $25,000. Elevated Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at about $26,000. Finally, WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at about $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 1.5%

NYSE:DHR opened at $199.62 on Wednesday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a market capitalization of $140.33 billion, a price-to-earnings ratio of 35.46, a PEG ratio of 2.52 and a beta of 0.78. The business’s 50-day moving average price is $193.74 and its two-hundred day moving average price is $192.50.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.77 EPS. On average, equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. UBS Group lowered their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Stifel Nicolaus reduced their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Guggenheim lowered their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Citigroup assumed coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Finally, Argus reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Check Out Our Latest Stock Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.